Exome sequencing identified mutations in CASK and MYBPC3 as the cause of a complex dilated cardiomyopathy phenotype.

Whole-exome sequencing for clinical applications is now an integral part of medical genetics practice. Though most studies are performed in order to establish diagnoses in individuals with rare and clinically unrecognizable disorders, due to the constantly decreasing costs and commercial availability, whole-exome sequencing has gradually become the initial tool to study patients with clinically recognized disorders when more than one gene is responsible for the phenotype or in complex phenotypes, when variants in more than one gene can be the cause for the disease. Here we report a patient presenting with a complex phenotype consisting of severe, adult-onset, dilated cardiomyopathy, hearing loss and developmental delay, in which exome sequencing revealed two genetic variants that are inherited from a healthy mother: a novel missense variant in the CASK gene, mutations in which cause a spectrum of neurocognitive manifestations, and a second variant, in MYBPC3, that is associated with hereditary cardiomyopathy. We conclude that although the potential for co-occurrence of rare diseases is higher when analyzing undefined phenotypes in consanguineous families, it should also be given consideration in the genetic evaluation of complex phenotypes in non-consanguineous families.

[1]  R. Pfundt,et al.  Phenotypic and molecular insights into CASK-related disorders in males , 2015, Orphanet Journal of Rare Diseases.

[2]  D. Behar,et al.  Mutations in TAX1BP3 Cause Dilated Cardiomyopathy with Septo‐Optic Dysplasia , 2015, Human mutation.

[3]  E. McNally,et al.  Genetic mutations and mechanisms in dilated cardiomyopathy. , 2013, The Journal of clinical investigation.

[4]  Steven B Marston,et al.  How do MYBPC3 mutations cause hypertrophic cardiomyopathy? , 2012, Journal of Muscle Research and Cell Motility.

[5]  Pablo Cingolani,et al.  © 2012 Landes Bioscience. Do not distribute. , 2022 .

[6]  E. Bertini,et al.  Spectrum of pontocerebellar hypoplasia in 13 girls and boys with CASK mutations: confirmation of a recognizable phenotype and first description of a male mosaic patient , 2012, Orphanet Journal of Rare Diseases.

[7]  杜昕,et al.  Inherited cardiomyopathies , 2012 .

[8]  H. Katus,et al.  Mechanisms of disease: hypertrophic cardiomyopathy , 2012, Nature Reviews Cardiology.

[9]  Soma Das,et al.  Phenotypic spectrum associated with CASK loss-of-function mutations , 2011, Journal of Medical Genetics.

[10]  M. Shaw,et al.  CASK mutations are frequent in males and cause X-linked nystagmus and variable XLMR phenotypes , 2010, European Journal of Human Genetics.

[11]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[12]  G. Lanfranchi,et al.  Hypertrophic cardiomyopathy: two homozygous cases with "typical" hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy. , 2003, Biochemical and biophysical research communications.

[13]  H Niimura,et al.  Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. , 1998, The New England journal of medicine.

[14]  H. Watkins,et al.  Inherited cardiomyopathies. , 2011, The New England journal of medicine.